Top Dublin Biotech Companies (30)
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized. The Solupore non-viral delivery system enables the next generation of cell therapies through unparalleled cell health and superior cell functionality, expanding the possibilities for complex editing and challenging cargo delivery. Easy to integrate into existing GMP processes, Solupore accelerates the translation of life-saving therapies to patients
Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions.
We are driving the future of animal health through technology that enables the agriculture industry to target treatment based on rapid, on-site diagnostics. Helping maximise yield and reduce costs all whilst helping to reduce environmental impact
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
We are a biotech longevity company on a mission to confront aging and age-related diseases. We’re building a coalition of the best scientists, physicians and investors to develop therapies and products that will help people experience better health for longer in their lives. We are organized to drive scientific innovation with speed and agility to market
Our commitment to The Science of Healthier Animals® guides our work. We offer our customers a range of technology solutions which fuse DNA and DATA intelligence to deliver unparalleled animal lifecycle knowledge and uniquely insightful connections. Together we can shape a better future for animal well-being and food trust
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
Opsona Therapeutics is a leading drug development company specialising in the human immune system. Opsona is identifying new ways to prevent and treat autoimmune/inflammatory conditions, cancers and infectious diseases. Opsona's drug discovery & development is focused on the role of Toll-Like Receptors (TLRs) and Inflammasome signalling in human immunology. Since 2004, Opsona has also developed a unique and advanced pipeline of drugs. The company has research locations in Dublin (Ireland) and Lausanne (Switzerland)
Our Vision is to bring an Insect Farming revolution to the world, to end the overexploitation of land and ocean and to ultimately add to the progress of the human race. With revolutionary breeding and bio-conversion technologies, we maximise the extraction of high-value protein and oil products for the aquaculture, animal feed and plant nutrition industries. Our process produces no waste, lowers GHG emissions, optimises land usage, utilises industrial and agricultural waste streams and improves animal nutrition and health. We are ready to feed the world
Sublimity Therapeutics is a clinical-stage biotechnology company dedicated to identifying and developing meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases. Led by a team of industry innovators and leveraging our Single-Multiple Pill (SmPill®) technology, we are advancing a diverse pipeline of oral small molecules that have the potential to make important contributions to human health. Our lead asset ST-0529 is currently being evaluated in the AURORA (CYC-202) Study, a Phase 2b clinical trial for moderate to severe Ulcerative Colitis
.png)
Ancestry is the global leader in family history and consumer genomics. Every day, around the world, we help curious people like you embark on journeys of personal discovery to enrich lives. With our unparalleled collection of more than 40 billion records from more than 80 countries and 23+ million people in our growing DNA network, Ancestry helps customers discover their family story and gain a new level of understanding about their lives. For 40 years, we’ve built trusted relationships with millions of people who have chosen us as the platform for discovering, preserving and sharing their story.
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. We hire the most brilliant minds because inventing for life depends on our work. Here, you'll find rewarding opportunities, diverse experiences, and an unwavering commitment to ethics and integrity. You'll collaborate with talented colleagues who share your sense of purpose. Our company will empower you to innovate, explore, and develop your full potential in our possibility-rich environment. Our team is constantly evolving, so if you are among the intellectually curious, join us—and start making your impact today.
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world
Astrix is the unrivaled market-leader in creating & delivering innovative strategies, solutions, and people to the life science community. Through world class people, process, and technology, Astrix works with clients to fundamentally improve business & scientific outcomes across many domains including the laboratory, clinical & regulatory, pharmacovigilance, R&D, and manufacturing. Founded by scientists to solve the unique challenges of the life science community, Astrix offers a growing array of strategic, application & platform, data transformation & analytics, change management, and staffing services designed to deliver immediate value to clients and solve their most complex technical and staffing challenges.
Technology for sustainable and cost-effective conversion of biomass waste into clean and drop-in advanced fuels for the marine, road and aviation sectors. Fuel is produced efficiently, at low-cost and with currently 85% fewer GHGs than traditional fossil fuel production, and hard at work to achieve carbon-neutral and negative fuels. Highlights include; an operational pilot plant deployed in Spain, patented technology, exciting project economics and a commercial-scale project underway in the UK with global partners. Keywords: Renewables, Transportation, Carbon Neutral, Decarbonisation, Biofuels, Advanced Fuels, Road, Marine, Aviation, Drop-in Fuels, dRTFCs, Development Fuel, CleanTech
Work Your Passion. Live Your Purpose.
